Destination Wealth Management Amgen Inc Transaction History

Destination Wealth Management

$3.19 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $3,226 - $3,894	12 Added 1.65%	738 $209,000
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $68,016 - $76,730	-266 Reduced 26.81%	726 $209,000
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $132,064 - $163,961	-604 Reduced 37.84%	992 $266,000
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $84,850 - $100,334	396 Added 33.0%	1,596 $354,000
Q1 2023 May 05, 2023	BUY	$225.79 - $275.2 $46,061 - $56,140	204 Added 20.48%	1,200 $290,000
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $37,789 - $48,016	-165 Reduced 14.21%	996 $261,000
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $68,909 - $77,717	-307 Reduced 20.91%	1,161 $262,000
Q2 2022 Jul 29, 2022	BUY	$230.71 - $256.74 $63,906 - $71,116	277 Added 23.26%	1,468 $357,000
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $39,468 - $43,662	-180 Reduced 13.13%	1,191 $288,000
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $1,193 - $1,365	-6 Reduced 0.44%	1,371 $308,000
Q3 2021 Oct 25, 2021	SELL	$212.27 - $248.7 $16,557 - $19,398	-78 Reduced 5.36%	1,377 $293,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $22,423 - $24,877	96 Added 7.06%	1,455 $355,000
Q1 2021 May 05, 2021	SELL	$221.91 - $258.6 $41,940 - $48,875	-189 Reduced 12.21%	1,359 $338,000
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $28,562 - $34,012	-132 Reduced 7.86%	1,548 $356,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $55,612 - $61,845	237 Added 16.42%	1,680 $427,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $65,277 - $80,104	-330 Reduced 18.61%	1,443 $340,000
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $2,915 - $3,867	16 Added 0.91%	1,773 $360,000
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $18,731 - $24,076	99 Added 5.97%	1,757 $424,000
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $172,543 - $206,742	991 Added 148.58%	1,658 $321,000
Q2 2019 Jul 19, 2019	SELL	$166.7 - $195.41 $30,506 - $35,760	-183 Reduced 21.53%	667 $123,000
Q1 2019 May 01, 2019	SELL	$180.87 - $203.88 $53,718 - $60,552	-297 Reduced 25.89%	850 $161,000
Q4 2018 Feb 05, 2019	SELL	$178.4 - $208.25 $713 - $833	-4 Reduced 0.35%	1,147 $223,000
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $94,683 - $106,742	511 Added 79.84%	1,151 $238,000
Q2 2018 Jul 31, 2018	SELL	$166.05 - $186.51 $53,302 - $59,869	-321 Reduced 33.4%	640 $118,000
Q1 2018 Apr 05, 2018	BUY	$169.43 - $198.0 $162,822 - $190,278	961 New	961 $164,000
Q3 2017 Nov 09, 2017	SELL	$167.29 - $191.0 $197,569 - $225,571	-1,181 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	1,181	1,181 $203,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Destination Wealth Management with notifications on news.

Account